Pfizer Inc.
PFE US
PFE USPfizer Inc.
United States Composite25.40
Recent
price
P/E
ratio
div
yld
6.45%
ROIC.AI
- Business
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Company News
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
US takes next step in Medicare drug price negotiations with pharma companies
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Roivant's anti-inflammatory drug succeeds in mid-stage study
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screamings Buys in April
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Pfizer (PFE) Stock Moves -0.11%: What You Should Know
Column: Conservative groups object to 'naming names' rule from Pfizer diversity decision
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
Bristol Myers' (BMY) Zeposia Fails Crohn's Disease Study
2 Stocks Down 30% and 27% to Buy and Hold
US scientists are leaving academia. That’s bad news for drug companies
5 FDA decisions to watch in the second quarter
Better Recovery Story Buy: Pfizer vs Moderna
Cramer's Lightning Round: Leidos is a winner
US CDC alerts healthcare providers of increase in meningococcal disease
20 Best Stocks to Buy Right Now According to Financial Media
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study
Moderna (MRNA) Posts Upbeat Data From Next-Gen COVID Jab Study